Bibliography

Found 23 results

Filters: Keyword is Male and Author is Simpson, David [Clear All Filters]

2019

Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.

Alakkas A, Ellis RJ, Watson CWei-Ming, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, et al. White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol. 2019 ;25(1):32-41.

2018

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, et al. Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States. J Int Neuropsychol Soc. 2018 ;24(2):163-175.

2017

Mehta SR, Pérez-Santiago J, Hulgan T, Day TRC, Barnholtz-Sloan J, Gittleman H, Letendre S, Ellis R, Heaton R, Patton S, et al. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. J Neuroinflammation. 2017 ;14(1):72.

Obermeit LC, Beltran J, Casaletto KB, Franklin DR, Letendre S, Ellis R, Fennema-Notestine C, Vaida F, Collier AC, Marra CM, et al. Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND. J Neurovirol. 2017 ;23(1):67-78.

2015

Clifford DB, Vaida F, Kao Y-ting, Franklin D, Letendre S, Collier AC, Marra CM, Gelman B, McArthur JC, Morgello S, et al. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people. Neurology. 2015 ;84(3):241-50.

Robinson-Papp JS, Sharma S, Dhadwal N, Simpson DM, Morgello S. Optimizing measures of HIV-associated neuropathy. Muscle Nerve. 2015 ;51(1):56-64.

2013

Morgan EE, Woods SPaul, Letendre S, Franklin D, Bloss C, Goate A, Heaton RK, Collier AC, Marra CM, Gelman B, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol. 2013 ;19(2):150-6.

Sakamoto M, Marcotte TD, Umlauf A, Franklin D, Heaton RK, Ellis RJ, Letendre S, Alexander T, McCutchan JA, Morgan EE, et al. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.

Nguyen A, Rossi S, Croteau D, Best BM, Clifford DB, Collier AC, Gelman B, Marra C, McArthur JC, McCutchan JA, et al. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.

Fennema-Notestine C, Ellis RJ, Archibald SL, Jernigan TL, Letendre S, Notestine RJ, Taylor MJ, Theilmann RJ, Julaton MD, Croteau D, et al. Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infection. J Neurovirol. 2013 ;19(4):393-401.

Marra CM, Deutsch R, Collier AC, Morgello S, Letendre S, Clifford DB, Gelman B, McArthur JC, McCutchan JA, Simpson DM, et al. Neurocognitive impairment in HIV-infected individuals with previous syphilis. Int J STD AIDS. 2013 ;24(5):351-5.

2011

Bharti AR, Letendre SL, Wolfson T, Clifford D, Collier AC, Gelman B, McArthur J, Marra C, McCutchan A, Morgello S, et al. Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol. 2011 ;52(4):328-32.

Lin K, Taylor MJ, Heaton R, Franklin D, Jernigan T, Fennema-Notestine C, McCutchan A, J Atkinson H, Ellis RJ, McArthur J, et al. Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals. J Clin Exp Neuropsychol. 2011 ;33(3):326-34.

Cysique LA, Franklin D, Abramson I, Ellis RJ, Letendre S, Collier A, Clifford D, Gelman B, McArthur J, Morgello S, et al. Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change. J Clin Exp Neuropsychol. 2011 ;33(5):505-22.

2010

Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T, Gelman BB, Vaida F, Collier A, Marra CM, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010 ;67(5):552-8.

Croteau D, Letendre S, Best BM, Ellis RJ, Breidinger S, Clifford D, Collier A, Gelman B, Marra C, Mbeo G, et al. Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1. Antimicrob Agents Chemother. 2010 ;54(12):5156-60.

2009

Robinson-Papp JS, Gonzalez-Duarte A, Simpson DM, Rivera-Mindt M, Morgello S. The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study. Journal of Acquired Immune Deficiency Syndromes (1999) [Internet]. 2009 ;51:569-573. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19521250

2008

Robinson-Papp JS, Byrd D, Mindt MRivera, Oden NL, Simpson DM, Morgello S. Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort. Archives of Neurology [Internet]. 2008 ;65:1096-101. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18695060

Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, J McCutchan A, Morgello S, et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008 ;65(1):65-70.

2007

Schifitto G, Navia BA, Yiannoutsos CT, Marra CM, Chang L, Ernst T, Jarvik JG, Miller EN, Singer EJ, Ellis RJ, et al. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS (London, England) [Internet]. 2007 ;21:1877-86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17721095

Letendre SL, Marquie-Beck J, Ellis RJ, Woods SPaul, Best B, Clifford DB, Collier AC, Gelman BB, Marra C, McArthur JC, et al. The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system. J Neuroimmune Pharmacol. 2007 ;2(1):120-7.